Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion-Reference-Cited by-同舟云学术

Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion

Published:2013-07-04 Issue:8 Volume:14 Page:446-450
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Cao Zhen Huan¹,Ma Li Na¹,Zhang Hong Wei¹,Liu Ya Li¹,Chen Xin Yue¹

Affiliation:

1. International Medical Department; Beijing You'an Hospital; Capital Medical University; Beijing; China

Publisher

Wiley

Subject

Gastroenterology

Reference19 articles.

1. uideline of prevention and treatment for chronic hepatitis B (2010 version);Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association;Chin J Gastroenterol,2011

2. Hepatitis B: an important public health issue;Maddrey;J Med Virol,2000

3. Chronic hepatitis B;Lok;Hepatology,2007

4. EASL Clinical Practice Guidelines: Management of chronic hepatitis B;European Association for the Study of the Liver;J Hepatol,2009

5. Pros and cons of peginterferon versus nucleos(t)ide analogues for treatment of chronic hepatitis B;Sonneveld;Curr Hepat Rep,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B cure: Current situation and prospects;World Journal of Hepatology;2024-06-27

2. Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure;Gastroenterology;2023-01

3. Can G-quadruplex become a promising target in HBV therapy?;Frontiers in Immunology;2022-12-15

4. Pegylated interferon‐α‐2b combined with tenofovir disoproxil fumarate, granulocyte‐macrophage colony‐stimulating factor, and hepatitis B vaccine treatment for naïve HBeAg‐positive chronic hepatitis B patients: A prospective, multicenter, randomized controlled study;Journal of Medical Virology;2022-07-19

5. A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients;Journal of Clinical and Experimental Hepatology;2022-05